Why the study?
Deep learning shows increasing promise in medicine, but its pros, cons, and viable directions for clinical use in cardiology required discussion.
Deep learning models show increasing promise for predictive modeling, data classification, and complicated decision making in clinical cardiology.
DL applications in cardiology warrant caution; leaves open rigorous validation before any clinical use.
Deep Learning (DL) is a novel type of Machine Learning (ML) model. It is showing an increasing promise in medicine, study and treatment of diseases and injuries, to assist in data classification, novel disease symptoms and complicated decision making. Deep learning is one of form of machine learning typically implemented via multi-level neural networks. This work discusses the pros and cons of using DL in clinical cardiology that is also applied in medicine in general while proposing certain directions as more viable for clinical use. DL models called Deep Neural Networks (DNNs), Recurrent Neural Networks (RNNs) and Convolutional Neural Networks (CNNs) have been applied to arrhythmias, electrocardiogram, ultrasonic analysis, genomes and endomyocardial biopsy. Convincingly, the results of the trained model are satisfactory, demonstrating the power of more expressive deep learning algorithms for clinical predictive modeling. In the future, more novel deep learning methods are expected to make a difference in the field of clinical medicines.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: